Financing channel feed – Endpoints News

Financing channel feed

The biopharma funding engine motors on, as Chinese biotech raises nearly $280M in monster round

6 years ago

In the heart of Texas, the AveXis crew gathers for another go at gene therapy with $30M and a powerhouse academic pact to start

6 years ago

Third Rock-backed startup's blood test can sniff out cancer in patients with no history of disease

6 years ago

Amid string of splashy pandemic IPOs, ADC returns for its millions

6 years ago

Boehringer Ingelheim VC backs plan to send GMO bacteria after tumors

6 years ago

An oncology upstart with some deep-pocket VC connections has a unicorn-sized venture round to back the pipeline

6 years ago

Mushroom magic draws $80M injection for London-based mental health startup

6 years ago

Nimbus founder Rosana Kapeller has a new company, with $50M and an eye on the ‘repeatome’

6 years ago

It's not developing drugs that bind to RNA, or morphing RNA into a therapeutic — this Cambridge startup has scored $63M to work on RNA-modifying proteins

6 years ago

Bain helps push Affinivax to next stage with $120M round, as PhII data loom on a lead effort to do something new in vaccines

6 years ago

Venrock joins the biotech VC fundraising game, tossing $447M into a $4.3B pot of new money

6 years ago

Analysis shows Swiss biotech index outshines Nasdaq counterpart, but coronavirus challenges are universal

6 years ago

Big Pharma VC firms put $11M in seed funds behind cancer startup with bold vision

6 years ago

Lantern Pharma charts course for IPO with AI platform that shines light on failed cancer drugs

6 years ago

Chinese antibody maker, famed for Ebola cocktail, notches $160M as it focuses on cancer, autoimmune drugs

6 years ago

Abundant funding, sparse data: San Francisco startup backs 'real world' model for rare disease drug development

6 years ago

The newest, $86M Third Rock startup chases the tiny biological machines inside of you

6 years ago

Touting new way of mining neuro targets, Takeda spinout draws $45M from GV, Bill Gates, Foresite

6 years ago

Tango Therapeutics nabs $60M in CRISPR-based hunt for hidden cancer genes

6 years ago

Qiming's China-focused $1.1B new fund brings global haul to $5B within 1 week — but the distribution won't be even

6 years ago

Weathering the storm: Another biotech braves Covid-19 in upsized IPO

6 years ago

Merck-partnered antibody maker readies $300M IPO as HKEX picks up pace

6 years ago

Another protein degradation biotech emerges, with the promise of a new approach from an old hand

6 years ago

Another day, another boatload for biotech. Deerfield adds $840M to rush of venture dollars

6 years ago

First page Previous page 99 100 101102103 104 105 Next page Last page